Adjuvant Radiotherapy for Stages II and III Resected Thymoma: a Single Institution Experience

PURPOSE: Role of adjuvant radiation for Masaoka stage II and III thymoma remains controversial. The aim of this study was to evaluate the clinical benefits of radiation therapy for resected stages II and III thymoma. METHODS AND MATERIALS: We retrospectively reviewed the medical records of 175 thymo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Clin Oncol
Auteurs principaux: Yan, Jinchun, Liu, Qin, Moseley, Jessica N., Baik, Christina S., Chow, Laura Q. M., Goulart, Bernardo H. M., Zlotnick, David, Papanicolau-Sengos, Antoni, Gallaher, Ian, Knopp, Joy M., Zeng, Jing, Patel, Shilpen
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5199721/
https://ncbi.nlm.nih.gov/pubmed/24517958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000044
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires